Skip to content

Cycling Deep Brain Stimulation on Parkinson's Disease Gait

Effects of Cycling Deep Brain Stimulation on Parkinson's Disease Gait

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04408573
Acronym
DBS
Enrollment
30
Registered
2020-05-29
Start date
2020-06-19
Completion date
2021-12-29
Last updated
2020-06-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson Disease

Brief summary

Our hypothesis is that cycling DBS stimulation would be superior or non-inferior to regular DBS stimulation in Parkinson's disease patients with gait impairment. The objective of this study is compare gait disorders in patients with Parkinson's disease and DBS in 4 different scenarios: 1) regular continuous high frequency (\>130Hz) stimulation, 2) cycling high frequency (\>130Hz) stimulation (40sec on, 2sec off), 3) low-frequency (80Hz) continuous stimulation and 4) cycling low frequency (80Hz) stimulation (40sec on, 2sec off)

Detailed description

Gait disorders such as falls, freezing of gait, reduction of speed, shuffling, and multi-stepped turning are common in patients with moderate and advanced Parkinson's disease. Compared to appendicular symptoms (bradykinesia, tremor, and rigidity), gait disorders tend to be more resistant to medical and regular deep brain stimulation treatment, and greatly impairs patients' quality of life and daily living activities. Some stimulation strategies have been tried to improve gait in Parkinson's disease patients, but so far most of them resulted in concomitant worsening of appendicular symptoms. However, new stimulation strategies such as cycling stimulation can potentially improve gait disorders without impairment of appendicular symptoms.

Interventions

OTHERCycling deep brain stimulation

Deep Brain Stimulation applied in cycling - periods of stimulation ON intercalated with periods of stimulation OFF

Sponsors

University of Sao Paulo General Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Intervention model description

2 weeks of regular continuous high frequency (\>130Hz) stimulation, 2 weeks of cycling high frequency (\>130Hz) stimulation (40sec on, 2sec off), 2 weeks of low-frequency (80Hz) continuous stimulation and 2 weeks of cycling low frequency (80Hz) stimulation (40sec on, 2sec off)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosis of idiopathic Parkinson's disease * Currently receiving Deep Brain Stimulation as a Parkinson's disease treatment * Hoehn & Yahr stage between 2-4 during off-medication * Underlying gait disorders despite optimal medical and stimulation treatment: score over or equal to 1 in the subitem 2.12 of the MDS-UPDRS scale * Willingness to comply with all study procedures

Exclusion criteria

* Active moderate/severe psychiatric condition * Active infection or other uncontrolled moderate/grave comorbidities * Treatment with experimental drug * Pregnancy or breast-feeding

Design outcomes

Primary

MeasureTime frameDescription
Change in the part II of the Unified Parkinson's disease rating scaleBaseline + after 2 weeks + after 4 weeks + after 6 weeksThe part II of the Unified Parkinson's disease rating scale (UPDRS II) is a self-reportable questionnaire consisting of 13 items that measure functionality (motor experiences of daily living). Scores vary from 0 - 52. Higher scores mean a worse outcome.
Change in the New Freezing of Gait QuestionnaireBaseline + after 2 weeks + after 4 weeks + after 6 weeksThe New Freezing of Gait Questionnaire (NFOG-Q) is a self-reportable questionnaire consisting of 9 items that measure freezing of gait (FOG). Scores vary from 0 - 28. Higher scores mean a worse outcome.

Secondary

MeasureTime frameDescription
Change in Falls Efficacy ScaleBaseline + after 2 weeks + after 4 weeks + after 6 weeksThe Falls Efficacy Scale (FES) is a sixteen-item test rated on a 10-point scale from not confident at all to completely confident. It is correlated with difficulty getting up from a fall and level of anxiety. Scores vary from 16 - 64. Higher scores mean a worse outcome.
Change in The Parkinson's Disease Questionnaire (PDQ-39)Baseline + after 2 weeks + after 4 weeks + after 6 weeksThis questionnaire assesses how often people affected by Parkinson's experience difficulties across 8 dimensions of daily living. The 39 item questionnaire offers a patient reported measure of health status and quality of life and is the most frequently used disease-specific health status measure.Scores vary from 0 - 156. Higher scores mean a worse outcome.
Change in Activities-Specific Balance Confidence Scale (ABC scale)Baseline + after 2 weeks + after 4 weeks + after 6 weeksThe ABC scale is a self-report measure of balance in performing various activities without losing balance or experiencing a sense of unsteadiness. Scores vary from 0 - 100. Higher scores mean a better outcome.
Number of fallsBaseline + after 2 weeks + after 4 weeks + after 6 weeksPatients will be questioned about number of times they experienced falls in the last 2 weeks. Higher numbers mean a worse outcome.

Countries

Brazil

Contacts

Primary ContactRubens G Cury, MD, PhD
rubens_cury@usp.br55 11 26617877
Backup ContactCarina C França, MD
carina.fr@usp.br55 11 26617877

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026